CV inflammation prevalence and clinical biomarkers (hsCRP, IL-6 and NT-proBNP) levels in adults with ASCVD and CKD in KSA and UAE: Insights from the INFLAMEAST real‑world study

31 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Real-world cardiorenal therapeutics: outcomes and mechanisms in advanced kidney disease Renal Failure and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology